Notify me when BC Global Opportunities IX LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 5.5% | $42,740,663 | 4,365,747 | BC Global Opportunities IX LP | 04 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|